Mesenchymal stem cells are a heterogeneous population of fibroblast‐like stromal cells that
have been isolated from the bone marrow and a number of organs and tissues including the …

PURPOSE: The potential use of stem cells for acute and chronic renal injury is under
intensive investigation. We summarized the current literature on the potential therapeutic …

Mesenchymal stem cells (MSC) are non‐haematopoietic cells that are prevalent in the adult
bone marrow but can also be isolated from a variety of other postnatal tissues. MSC are non …

Every year 13.3 million people suffer acute kidney injury (AKI), which is associated with a
high risk of death or development of long-term chronic kidney disease (CKD) in a substantial …

Numerous preclinical and clinical studies suggest that mesenchymal stem cells, also known
as multipotent mesenchymal stromal cells (MSCs), may improve pathologic conditions …

The potential role of mesenchymal stem cells (MSCs, also called mesenchymal stromal
cells) in endogenous repair and cell-based therapies for acute kidney injury (AKI) is under …

Ischemic kidney diseases are common clinical entities that bear high mortality and morbidity
and may lead to irreversible loss of kidney function. Their pathophysiology is multifaceted …

Mesenchymal stem cells (MSCs) ameliorate injury and accelerate repair in many organs,
including the kidney, although the reparative mechanisms and interaction with macrophages …

BACKGROUND: Ischemia and reperfusion injury (I/R) is the major cause of acute renal
failure (ARF) with high mortality rates. Because alternative therapies are needed, we …

Multipotent mesenchymal stromal cells from the bone marrow ameliorate acute kidney injury
through a mechanism other than transdifferentiation into renal tissue. Stromal cells exert …